Cutaneous adverse reactions in a lung cancer patient treated with pembrolizumab: A case report.

MLA

Bobeica, Carmen, et al. “Cutaneous Adverse Reactions in a Lung Cancer Patient Treated with Pembrolizumab: A Case Report.” Experimental and Therapeutic Medicine, vol. 23, no. 1, Jan. 2022, p. 15. EBSCOhost, https://doi.org/10.3892/etm.2021.10937.

APA

Bobeica, C., Rebegea, L., Murariu, G., Dobre, M., Nechita, A., Tatu, A. L., Niculet, E., Anghel, L., Fotea, S., & Craescu, M. (2022). Cutaneous adverse reactions in a lung cancer patient treated with pembrolizumab: A case report. Experimental and Therapeutic Medicine, 23(1), 15. https://doi.org/10.3892/etm.2021.10937

Chicago

Bobeica, Carmen, Laura Rebegea, Gabriel Murariu, Michaela Dobre, Aurel Nechita, Alin Laurentiu Tatu, Elena Niculet, Lucretia Anghel, Silvia Fotea, and Mihaela Craescu. 2022. “Cutaneous Adverse Reactions in a Lung Cancer Patient Treated with Pembrolizumab: A Case Report.” Experimental and Therapeutic Medicine 23 (1): 15. doi:10.3892/etm.2021.10937.